Clinical Practice Management Guideline for Ventilator-Associated Pneumonia: Diagnosis, Treatment & Prevention
|
|
- Benedict Benson
- 5 years ago
- Views:
Transcription
1 Clinical for Ventilator-Associated Pneumonia: Diagnosis, Treatment & Prevention Background Ventilator-associated pneumonia (VAP), a pneumonia that develops 48hrs after initiation of mechanical ventilation, is the most prevalent infection encountered in the intensive care unit (ICU). This has led to countless of discussions about diagnosis, treatment, and prevention due to the associated morbidity, mortality, and cost VAP occurs in roughly 20% of ICU patients with mortality ranging from 20-50% , 14 To improve upon early diagnosis and treatment of these patients, the CDC published a set of guidelines to aid with early detection and treatment of patients who were at risk for developing VAP. 2-3 Despite this, the diagnosis of VAP remained elusive, especially in the multi-trauma patient. Multiple studies have shown the futility of using scoring systems such as the Clinical Pulmonary Infection Score (CPIS) to diagnose and treat pneumonia in the trauma patient. 16 The triggers used in these scoring systems can also be seen in patients with multiple traumatic injuries secondary to the inflammatory response, chest trauma (i.e. pulmonary contusions, atelectasis, lobar collapse), or as a result of resuscitation (i.e. pulmonary edema, worsening pulmonary contusions, TRALI, etc.). Using these methods will result in over-diagnosis of VAP with concomitant over-usage of antimicrobial agents and promote drug resistance. 4-6 As such, there is now data from a few centers to support the use of well-defined algorithms based on clinical & objective (via quantitative cultures) data to aid with the diagnosis & treatment of VAP. In addition, the CDC updated its guideline in Jan in the form of an algorithm titled Ventilator Associated Events which is reminiscent of the algorithms proposed by the aforementioned centers. Nonetheless, there are guidelines present, via the use of quantitative cultures, to aid with a more accurate diagnosis of VAP and appropriately targeted antimicrobial therapy. Goals 1. To promptly identify patients at risk for developing, or have developed, VAP. 2. To demonstrate a method of diagnosing VAP. 3. To streamline treatment options for VAP by clinical & objective data. 4. To identify methods for prevention of VAP. Page 1
2 Work-up/DIagnosis 1. Impaired gas exchange is defined as oxygen desaturations requiring increased oxygen requirements (increased FiO2) or ventilator demand. It also includes a decreasing P:F ratio (< 240). A patient with impaired gas exchanged in addition to THREE of the findings below should be worked up further for possible VAP: - Abnormal temperature (>38 C or <36 C). - Abnormal WBC (>12,000 cells/mm 3 or <4,000 cells/mm 3 ) or presence of > 10% bands. - Macroscopically purulent sputum. - New or changing infiltrate on chest radiograph. 2. Bronchoscopy with bronchoalveolar lavage (BAL) should be performed. Specimen should be sent for quantitative culture only. Respiratory cultures are of no use for diagnosis and should not be obtained. Procedure should include five aliquots of 20 ml saline injected via the bronchoscope into the most worrisome lobar bronchus with aspiration into a sputum trap. 4 One large bolus of 100 ml of sterile saline may also be used. 11 All mucus plugs need to be cleared prior to the procedure. Furthermore, the bronchoscope channel needs to be cleared with sterile saline PRIOR to obtaining the BAL sample to decrease the chances of false negative results. If bronchoscopy is not indicated, or available, a mini-bal is adequate. As with the specimen obtained via bronchoscopy, this specimen is also sent for quantitative cultures. 3. A diagnosis of VAP is made if the BAL has > 10 5 cfu/ml (> 10 4 cfu/ml for mini-bal) AND the patient has been on mechanical ventilation for more than TWO calendar days. 4-5 Treatment 1. Antibiotics are not to be initiated until after the initial results have been posted unless it is in the setting of sepsis. This is in an attempt to promote antibiotic stewardship and decrease the risk of developing drug-resistant bacteria within the institution Empiric antibiotics should be dictated by the current hospital antibiograms Antibiotics, once initiated, should be narrowed as soon as possible. Antibiotic treatment length is 7 days Repeat BAL (via bronch or mini-bal) should be performed on Day #4 of antibiotic therapy if patient continues to show clinical signs of VAP. a. If the BAL shows < 10 4 cfu/ml (10 3 cfu/ml for mini-bal) of the same organism, antibiotics to be discontinued after 7 days as planned. Page 2
3 b. If the BAL shows > 10 4 cfu/ml (10 3 cfu/ml for mini-bal) of the same organism, antibiotics should be continued for a total course of 14 days. 5. Quantitative cultures that grow Pseudomonas, ESBL, Stenotrophomonas or Acinetobacter (non- glucose fermenting gram negative bacilli) should be treated for a minimum of 14 days as shorter duration of treatment is associated with higher rates of recurrence with these organisms Antibiotic therapy should be discontinued if cx results are negative. 6, 10 Prevention While the above is meant to promptly diagnose and treat VAP, the presence of VAP still confers an increase in hospital length of stay and costs. The below guidelines are methods used to prevent the development of VAP. 8, 15 Subglottic suctioning Change of circuit for each patient and if the circuit becomes soiled or damaged. Frequent rotation Elevation of HOB at 45 (no lower than 30 ) Humidifier change every 5-7 days. Oral chlorohexidine gluconate Use of MDI vs. nebulizer when indicated Closed endotracheal suctioning. Daily spontaneous breathing trials (when indicated) Avoidance of gastric distension Maintaining cuff pressure < 20cm H 2O. Discontinuation of stress ulcer prophylaxis when appropriate (unless a home medication). Consider using sulcrafate instead if GI tract is able to be used. Page 3
4 References 1. Magill SS, Klompas M, Balk R, et al. Developing a new, national approach to surveillance for ventilator-associated events. Crit Care Med. 2013; 41(11): Ventilatory-Associated Pneumonia (VAP) Event. Device-associated Events. CDC. January Ventilatory-Assoicated Event (VAE). Device-associated Module. CDC. January Croce MA, Fabian TC, Mueller EW, et. al. The Appropriate Diagnostic Threshold for Ventilator- Associated Pneumonia Using Quantitative Cultures. J Trauma 2004; 56(5): Sharpe JP, Magnotti LJ, Weinberg JA, et al. Adherence to an established diagnostic threshold for ventilator-associated pneumonia contributes to low false-negative rates in trauma patients. J Trauma Acute Care Surg 2015; 78(3): Hranjec T, Rosenberger LH, Swenson B, et. al. Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive care unit acquired infection: a quasi-experimental before and after observational cohort study. Lancet Infect Dis 2012; 12: Koenig SM, Truwit JD. Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention. Clinical Microbiology Reviews 2006; 19(4): Muscedere J, Dodeck P, Keenan S, et. al. Comprehenisive evidence-based clinical practice guidelines for ventilator-associated pneumonia: Prevention. Journal of Critical Care 2008; 23: Croce MA, Swanson JM, Magnotti LJ, et. al. The Futility of the Clinical Pulmonary Infection Score in Trauma Patients. J Trauma 2006; 60(3): Kalil AC, Metersky ML, Klompas M, et. al. Management of Adults With Hospital-Acquired and Ventilator-Assoicated Pneumonia: 2016 Clinical Practice s by the Infectious Diseases Society of America and the American Thoracic Society. Clinical Infectious Diseases Kalanuria AA, Ziai W, Mirski M. Ventilator-associated Pneumonia in the ICU. Critical Care 2014; 18: Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and Economic Consequences of Ventilator- associated Pnemonia: A Systematic Review. Critical Care Medicine 2005; 33(10): Restrepo MI, Anzueto A, Arroliga AC, Afessa B, et. al. Economic Burden of Ventilator- Associated Pneumonia Based on Total Resource Utilization. Infection Control & Hospital Epidemiology 2010; 31(5): Annual Hospital-Acquired Condition Rate and Estimates of Cost Savings and Deaths Averted From 2010 to Agency for Heathcare Research and Quality. October Klompas M, Branson R, Eichenwald EC, Greene LR, et. al. Strategies to Prevent Ventilator- Associated Pneumonia in Acute Care Hostpitals: 2014 Update. Infection Control & Hospital Page 4
5 Epidemiology 2014; 35: s Parks NA, Magnotti LJ, Weinberg JA, Zarzaur BL, et. al. Use of the clinical pulmonary infection score to guide therapy for ventilator-associated pneumonia risks antibiotic overexposure in patients with trauma. J Trauma Acute Care Surg 2012; 73(1): Swanson JM, Connor KA, Magnotti LJ, Croce MA, et al. Resolution of Clinical and Laboratory Abnormalities after Diagnosis of Ventilator-Associated Pneumonia in Trauma Patients. Surgical Infections 2013; 14(1): Page 5
6 VAP Algorithm Concern for sepsis NO YES Clinical Suspicion of VAP Fiberoptic Bronchoscopy with BAL or mini-bal Pan culture, including BAL. Start broad-spectrum antibiotics. Initial Results No growth to date Insignificant growth (<100,000 cfu/ml) Significant growth (>100,000 cfu/ml) Continue to hold antibiotics Start antibiotics specific for bacteria (narrow when applicable) Seven days of antibiotic treatment. **If growing Pseudomonas, ESBL, Stenotrophomonas, or Acinetobactor treatment should be 14 days. Page 6
ANWICU knowledge
ANWICU knowledge www.anwicu.org.uk This presenta=on is provided by ANWICU We are a collabora=ve associa=on of ICUs in the North West of England. Permission to provide this presenta=on has been granted
More informationNew Surveillance Definitions for VAP
New Surveillance Definitions for VAP 2012 Critical Care Canada Forum Toronto Dr. John Muscedere Associate Professor of Medicine, Queen s University Kingston, Ontario Presenter Disclosure Dr. J. G. Muscedere
More informationVentilator Associated
Ventilator Associated Pneumonia: Key and Controversial Issues Christopher P. Michetti, MD, FACS Inova Fairfax Hospital, Falls Church, VA Forrest Dell Moore, MD, FACS Banner Healthcare System, Phoenix,
More informationLâcher les VAP pour les VAC, les IVAC?...(CDC) INTRODUCTION
Lâcher les VAP pour les VAC, les IVAC?...(CDC) lila.bouadma@bch.aphp.fr INTRODUCTION VAP surveillance is needed to measure incidence and to gauge the success of prevention efforts. However, VAP diagnosis
More informationPneumonia (PNEU) and Ventilator-Associated Pneumonia (VAP) Prevention. Basics of Infection Prevention 2-Day Mini-Course 2016
Pneumonia (PNEU) and Ventilator-Associated Pneumonia (VAP) Prevention Basics of Infection Prevention 2-Day Mini-Course 2016 Objectives Differentiate long term care categories of respiratory infections
More informationCommunity Acquired & Nosocomial Pneumonias
Community Acquired & Nosocomial Pneumonias IDSA/ATS 2007 & 2016 Guidelines José Luis González, MD Clinical Assistant Professor of Medicine Outline Intro - Definitions & Diagnosing CAP treatment VAP & HAP
More informationAccurate Diagnosis Of Postoperative Pneumonia Requires Objective Data
Accurate Diagnosis Of Postoperative Pneumonia Requires Objective Data David Ebler, MD David Skarupa, MD Andrew J. Kerwin, MD, FACS Jhun de Villa, MD Michael S. Nussbaum, MD, FACS J.J. Tepas III, MD, FACS
More informationCHEST VOLUME 117 / NUMBER 4 / APRIL, 2000 Supplement
CHEST VOLUME 117 / NUMBER 4 / APRIL, 2000 Supplement Evidence-Based Assessment of Diagnostic Tests for Ventilator- Associated Pneumonia* Executive Summary Ronald F. Grossman, MD, FCCP; and Alan Fein, MD,
More informationVAP Definitions. CDC New Approach to VAP Surveillance. Conflict of Interest Disclosure Robert M Kacmarek. Artificial Airways, Cuffs, Bioflim and VAP
Conflict of Interest Disclosure Robert M Kacmarek Artificial Airways, Cuffs, Bioflim and VAP Bob Kacmarek PhD, RRT Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 9-14-18
More informationResearch & Reviews of. Pneumonia
Chapter Clinical Presentation and Diagnosis of VAP in Adult ICU Patients Priyam Batra * ; Purva Mathur Research & Reviews of Department of Laboratory Medicine, AIIMS, Trauma Centre, New Delhi, India. *
More informationHEALTHCARE-ASSOCIATED PNEUMONIA: DIAGNOSIS, TREATMENT & PREVENTION
HEALTHCARE-ASSOCIATED PNEUMONIA: DIAGNOSIS, TREATMENT & PREVENTION David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics, & Epidemiology Associate Chief Medical Officer, UNC Health Care Medical
More informationDiagnosis of Ventilator- Associated Pneumonia: Where are we now?
Diagnosis of Ventilator- Associated Pneumonia: Where are we now? Gary French Guy s & St. Thomas Hospital & King s College, London BSAC Guideline 2008 Masterton R, Galloway A, French G, Street M, Armstrong
More informationHospital-acquired Pneumonia
Hospital-acquired Pneumonia Hospital-acquired pneumonia (HAP) Pneumonia that occurs at least 2 days after hospital admission. The second most common and the leading cause of death due to hospital-acquired
More informationVentilator associated events, conditions and prevention of VAP. Dr.Pratap Upadhya
Ventilator associated events, conditions and prevention of VAP Dr.Pratap Upadhya Introduction Pathogenesis of vap Diagnosis of vap Ventilator-Associated Events: New Terminology and Its Relationship to
More informationVAP Are strict diagnostic criteria advisable?
VAP Are strict diagnostic criteria advisable? Javier Garau, MD, PhD 18th Infection and Sepsis Symposium, Porto, 27th February 2013 Limitations of current definitions Alternatives -Streamlined definition
More informationVAP Prevention bundles
VAP Prevention bundles Dr. Shafiq A.Alimad MD Head of medical department at USTH YICID workshop, 15-12-2014 Care Bundles What are they & why use them? What are Care Bundles? Types of Care Bundles available
More informationChallenges in Diagnosis, Surveillance and Prevention of Ventilator-associated pneumonia
Challenges in Diagnosis, Surveillance and Prevention of Ventilator-associated pneumonia Massachusetts Coalition for the Prevention of Errors November 6, 2008 Michael Klompas MD, MPH, FRCPC Brigham and
More informationNosocomial Pneumonia. <5 Days: Non-Multidrug-Resistant Bacteria
Nosocomial Pneumonia Meredith Deutscher, MD Troy Schaffernocker, MD Ohio State University Burden of Hospital-Acquired Pneumonia Second most common nosocomial infection in the U.S. 5-10 episodes per 1000
More informationVentilator Associated Pneumonia: New for 2008
Ventilator Associated Pneumonia: New for 2008 Jeanine P. Wiener-Kronish, MD Henry Isaiah Dorr Professor of Research and Teaching in Anaesthetics and Anaesthesia Department of Anesthesia and Critical Care
More informationVentilator Associated Pneumonia. ICU Fellowship Training Radboudumc
Ventilator Associated Pneumonia ICU Fellowship Training Radboudumc Attributable mortality VAP Meta-analysis of individual patient data from randomized prevention studies Attributable mortality mainly results
More informationVentilator Associated Pneumonia Vap
Ventilator Associated Pneumonia Vap 1 / 6 2 / 6 3 / 6 Ventilator Associated Pneumonia Vap Ventilator-associated pneumonia is a lung infection that develops in a person who is on a ventilator. A ventilator
More informationVentilator Associated Pneumonia. ICU Fellowship Training Radboudumc
Ventilator Associated Pneumonia ICU Fellowship Training Radboudumc Attributable mortality VAP Meta-analysis of individual patient data from randomized prevention studies Attributable mortality mainly results
More informationVentilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention
CLINICAL MICROBIOLOGY REVIEWS, Oct. 2006, p. 637 657 Vol. 19, No. 4 0893-8512/06/$08.00 0 doi:10.1128/cmr.00051-05 Copyright 2006, American Society for Microbiology. All Rights Reserved. Ventilator-Associated
More informationinfection control and hospital epidemiology january 2008, vol. 29, no. 1 original article
infection control and hospital epidemiology january 2008, vol. 29, no. 1 original article Development of an Algorithm for Surveillance of Ventilator-Associated Pneumonia With Electronic Data and Comparison
More informationDisclosures. Objectives. Procalcitonin: Pearls and Pitfalls in Daily Practice
Procalcitonin: Pearls and Pitfalls in Daily Practice Sarah K Harrison, PharmD, BCCCP Clinical Pearl Disclosures The author of this presentation has no disclosures concerning possible financial or personal
More informationMoving from VAP to VAC
Moving from VAP to VAC Cindy Munro, PhD, RN, ANP-BC, FAANP, FAAN Associate Dean of Research and Innovation Professor College of Nursing Conflict of interest: No relationships with pharmaceutical companies,
More informationTrial protocol - NIVAS Study
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Trial protocol - NIVAS Study METHODS Study oversight The Non-Invasive Ventilation after Abdominal Surgery
More informationTELEFLEX ISIS TM. Better access. Best practice.
TELEFLEX ISIS TM HVT Better access. Best practice. SUBGLOTTIC SECRETION REMOVAL: A VAP REDUCTION STRATEGY. Ventilator-Associated Pneumonia (VAP) is a nosocomial pneumonia that develops more than 48 hours
More informationGuess or get it right?
Guess or get it right? Antimicrobial prescribing in the 21 st century Robert Masterton Traditional Treatment Paradigm Conservative start with workhorse antibiotics Reserve more potent drugs for non-responders
More informationAntimicrobial Stewardship in Community Acquired Pneumonia
Antimicrobial Stewardship in Community Acquired Pneumonia Medicine Review Course 2018 Dr Lee Tau Hong Consultant Department of Infectious Diseases National Centre for Infectious Diseases Scope 1. Diagnosis
More informationInfection Control. Craig M Coopersmith, MD
Infection Control Craig M Coopersmith, MD Professor of Surgery Director, Surgical Intensive Care Unit Associate Director Emory Center for Critical Care Financial disclosure I have received grant support
More informationChapter 22. Pulmonary Infections
Chapter 22 Pulmonary Infections Objectives State the incidence of pneumonia in the United States and its economic impact. Discuss the current classification scheme for pneumonia and be able to define hospital-acquired
More informationKIMBERLY-CLARK* MICROCUFF* Endotracheal Tube.. Revolutionary cuff material designed to reduce micro-aspiration
KIMBERLY-CLARK* MICROCUFF* Endotracheal Tube.. Revolutionary cuff material designed to reduce micro-aspiration Ventilator-Associated Pneumonia VAP is a major clinical concern...... associated with high
More informationBronchoalveolar lavage (BAL) with surfactant in pediatric ARDS
Bronchoalveolar lavage (BAL) with surfactant in pediatric ARDS M. Luchetti, E. M. Galassini, A. Galbiati, C. Pagani,, F. Silla and G. A. Marraro gmarraro@picu.it www.picu.it Anesthesia and Intensive Care
More informationData Collection Tool. Standard Study Questions: Admission Date: Admission Time: Age: Gender:
Data Collection Tool Standard Study Questions: Admission Date: Admission Time: Age: Gender: Specifics of Injury: Time of Injury: Mechanism of Injury Blunt vs Penetrating? Injury Severity Score? Injuries:
More informationSevere β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy
Recommended Empirical Antibiotic Regimens for MICU Patients Notes: The antibiotic regimens shown are general guidelines and should not replace clinical judgment. Always assess for antibiotic allergies.
More informationCare Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT
Care Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT Target Audience: All MHS employed providers within Primary Care, Urgent Care, and In-Hospital Care. The secondary audience
More informationNeonatal Airway Disorders, Treatments, and Outcomes. Steven Goudy, MD Pediatric Otolaryngology Emory University Medical Center
Neonatal Airway Disorders, Treatments, and Outcomes Steven Goudy, MD Pediatric Otolaryngology Emory University Medical Center Disclosure I have nothing to disclose Neonatal and Pediatric Tracheostomy Tracheostomy
More informationPneumonia (Ventilator-associated [VAP] and non-ventilator-associated Pneumonia [PNEU]) Event
Pneumonia (Ventilator-associated [VAP] and non-ventilator-associated Pneumonia []) Event Introduction: In 2011, an estimated 157,000 healthcare-associated pneumonias occurred in acute care hospitals in
More informationHEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY
HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics, & Epidemiology Associate Chief Medical Officer, UNC Health
More informationHandling Common Problems & Pitfalls During. Oxygen desaturation in patients receiving mechanical ventilation ACUTE SEVERE RESPIRATORY FAILURE
Handling Common Problems & Pitfalls During ACUTE SEVERE RESPIRATORY FAILURE Pravit Jetanachai, MD QSNICH Oxygen desaturation in patients receiving mechanical ventilation Causes of oxygen desaturation 1.
More informationVentilator-Associated Event (VAE) For use in adult locations only
Ventilator-Associated Event () For use in adult locations only Table of Contents: Introduction 1 Settings 3 Definitions 3 Reporting Instructions 16 Figures 1-4, Algorithm 18 Numerator Data 23 Denominator
More informationHospital Acquired Pneumonias
Hospital Acquired Pneumonias Hospital Acquired Pneumonia ( HAP ) Hospital acquired pneumonia ( HAP ) is defined as an infection of the lung parenchyma developing during hospitalization and not present
More informationSUBGLOTTIC SECRETION REMOVAL:
ARROW REGIONAL TELEFLEX ANAESTHESIA ISIS Nullan utpat, Better vulputpatie access. ero Best dion practice. ulputat SUBGLOTTIC SECRETION REMOVAL: A VAP REDUCTION STRATEGY Ventilator-Associated Pneumonia
More informationVentilator Associated Events
Ventilator Associated Events Background: Why we monitor Prevention and control of healthcare-associated pneumonia is discussed in the CDC/HICPAC document, Guidelines for Prevention of Healthcare- Associated
More informationWhat is the next best step?
Noninvasive Ventilation William Janssen, M.D. Assistant Professor of Medicine National Jewish Health University of Colorado Denver Health Sciences Center What is the next best step? 65 year old female
More informationCARE OF THE ADULT PNEUMONIA PATIENT
Care Guideline CARE OF THE ADULT PNEUMONIA PATIENT Target Audience: The target audience for this Care Guideline is all MultiCare providers and staff, including those associated with our clinically integrated
More informationMRSA pneumonia mucus plug burden and the difficult airway
Case report Crit Care Shock (2016) 19:54-58 MRSA pneumonia mucus plug burden and the difficult airway Ann Tsung, Brian T. Wessman An 80-year-old female with a past medical history of chronic obstructive
More informationMICROBIOLOGICAL TESTING IN PICU
MICROBIOLOGICAL TESTING IN PICU This is a guideline for the taking of microbiological samples in PICU to diagnose or exclude infection. The diagnosis of infection requires: Ruling out non-infectious causes
More informationAmerican College of Surgeons Critical Care Review Course 2012: Infection Control
American College of Surgeons Critical Care Review Course 2012: Infection Control Overview: I. Central line associated blood stream infection (CLABSI) II. Ventilator associated pneumonia (VAP) I. Central
More informationPotential Conflicts of Interests
Potential Conflicts of Interests Research Grants Agency for Healthcare Research and Quality Akers Bioscience, Inc. Pfizer, Inc. Scientific Advisory Boards Pfizer, Inc. Cadence Pharmaceuticals Kimberly
More informationBronchoscopy SICU Protocol
Bronchoscopy SICU Protocol Updated January 2013 Outline Clinical indications Considerations Preparation Bronchoscopy technique Bronchoalveolar Lavage (BAL) Post-procedure Purpose Bronchoscopy is a procedure
More informationUPDATE IN HOSPITAL MEDICINE
UPDATE IN HOSPITAL MEDICINE FLORIDA CHAPTER ACP MEETING 2016 Himangi Kaushal, M.D., F.A.C.P. Program Director Memorial Healthcare System Internal Medicine Residency DISCLOSURES None OBJECTIVES Review some
More informationTHE MICROBIOLOGICAL PROFILE OF VENTILATOR ASSOCIATED PNEUMONIA.
THE MICROBIOLOGICAL PROFILE OF VENTILATOR ASSOCIATED PNEUMONIA. Dr. Poonam C. Sharma, Dr. S. S. Raut, Dr. S. R. More, Dr. V. S. Rathod, Dr. V. M. Gujar. 1. Post Graduate Student, Department of Microbiology,
More informationIS YOUR CUFF DOING THE JOB?
MICROCUFF * Endotracheal Tubes IS YOUR CUFF DOING THE JOB? Polyurethane cuff and subglottic secretion drainage help prevent early- and late-onset VAP 1 LEADING AUTHORITIES: SUBGLOTTIC SUCTIONING IS A BEST
More informationNonbronchoscopic bronchoalveolar lavage for diagnosing ventilator-associated pneumonia in newborns
The Turkish Journal of Pediatrics 2006; 48: 213-220 Original Nonbronchoscopic bronchoalveolar lavage for diagnosing ventilator-associated pneumonia in newborns Nilgün Köksal 1, Mustafa Hacımustafaoğlu
More information1.40 Prevention of Nosocomial Pneumonia
1.40 Prevention of Nosocomial Pneumonia Purpose Audience Policy Statement: The guideline is designed to reduce the incidence of pneumonia and other acute lower respiratory tract infections. All UTMB healthcare
More informationRESPIRATORY COMPLICATIONS AFTER SCI
SHEPHERD.ORG RESPIRATORY COMPLICATIONS AFTER SCI NORMA I RIVERA, RRT, RCP RESPIRATORY EDUCATOR SHEPHERD CENTER 2020 Peachtree Road, NW, Atlanta, GA 30309-1465 404-352-2020 DISCLOSURE STATEMENT I have no
More informationCase Study #2. Case Study #1 cont 9/28/2011. CAPA 2011 Christy Wilson PA C. LH is 78 yowf with PMHx of metz breast CA presents
Case Study #1 CAPA 2011 Christy Wilson PA C 46 yo female presents with community acquired PNA (CAP). Her condition worsened and she was transferred to the ICU and placed on mechanical ventilation. Describe
More informationLecture Notes. Chapter 16: Bacterial Pneumonia
Lecture Notes Chapter 16: Bacterial Pneumonia Objectives Explain the epidemiology Identify the common causes Explain the pathological changes in the lung Identify clinical features Explain the treatment
More informationHealthcare-associated infections acquired in intensive care units
SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Healthcare-associated infections acquired in intensive care units Key facts In 2015, 11 788 (8.3%) of patients staying in an intensive care unit
More informationVentilator-Associated Events (VAEs): Reduction and Reporting
Ventilator-Associated Events (VAEs): Reduction and Reporting June 21, 2016 Agenda Opening Remarks Housekeeping Polling Question Presentations Q&A Closing Remarks 2 Introduction to the atom Alliance Multi-state
More informationUsefulness of Procalcitonin in the management of Infections in ICU. P Damas CHU Sart Tilman Liège
Usefulness of Procalcitonin in the management of Infections in ICU P Damas CHU Sart Tilman Liège Procalcitonin Peptide 116 AA Produced by parenchymal cells during «sepsis»: IL1, TNF, IL6 : stimulators
More informationVentilator-Associated Pneumonia in Neonatal and Pediatric Intensive Care Unit Patients
CLINICAL MICROBIOLOGY REVIEWS, July 2007, p. 409 425 Vol. 20, No. 3 0893-8512/07/$08.00 0 doi:10.1128/cmr.00041-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. Ventilator-Associated
More informationAll previously published papers and figures were reproduced with permission from the publisher.
All previously published papers and figures were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by Larserics Digital Print AB. Petra Hyllienmark, 2013 ISBN ISBN
More informationAcute respiratory failure
Rita Williams, NP-C, PA PeaceHealth Medical Group Pulmonary & Critical Care Acute respiratory failure Ventilation/perfusion mismatching Most common cause of hypoxemia Normal is 1:1 ratio or 1 Ventilation
More informationShilla Patel OD, CIC UC San Diego Health System Infection Prevention/Clinical Epidemiology
Shilla Patel OD, CIC snp006@ucsd.edu UC San Diego Health System Infection Prevention/Clinical Epidemiology Name 3 adverse outcomes of VAE events Identify 4 most common causes of VAE Review latest research
More informationContraindications to time critical surgery; when not to proceed from the perspective of: The Physician A/Prof Peter Morley
Contraindications to time critical surgery; when not to proceed from the perspective of: The Physician A/Prof Peter Morley British Journal of Surgery 2013; 100: 1045 1049 The risk of 30 day mortality
More informationEvaluation of the Infection-Related Ventilator-Associated Events Algorithm for Ventilator-Associated Pneumonia Surveillance in a Trauma Population
Evaluation of the Infection-Related Ventilator-Associated Events Algorithm for Ventilator-Associated Pneumonia Surveillance in a Trauma Population Annop Piriyapatsom MD, Hsin Lin PharmD, Massimiliano Pirrone
More informationImplementation and evaluation of the impact of a "ventilator-bundle at Kinshasa University Clinics: Before and after study.
Research Article http://www.alliedacademies.org/journal-infectious-diseases-medical-microbiology/ Implementation and evaluation of the impact of a "ventilator-bundle at Kinshasa University Clinics: Before
More informationTargeted literature review:
Targeted literature review: What are the key infection prevention and control recommendations to inform a minimising ventilator associated pneumonia (VAP) quality improvement tool? Part of HAI Delivery
More informationVentilator-associated Complications In The Mechanically Ventilated Veteran
University of Central Florida Electronic Theses and Dissertations Doctoral Dissertation (Open Access) Ventilator-associated Complications In The Mechanically Ventilated Veteran 2013 Joan Grano University
More informationDr.Sivaramakrishnan PICU KKCTH
Dr.Sivaramakrishnan PICU KKCTH CASE 1 11/2 year old female child Known wheezer on intermittent bronchodilators Admitted with h/o cough for 2 days Increased work of breathing for 1 day Afebrile/sick looking
More informationBIP Endotracheal Tube
Bactiguard Infection Protection BIP Endotracheal Tube For prevention of healthcare associated infections Ventilator associated pneumonia Infections of the respiratory tract are serious and common healthcare
More informationChapter 8. Other Important Tests and Procedures. Mosby items and derived items 2011, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Chapter 8 Other Important Tests and Procedures 1 Introduction Additional important diagnostic studies include: Sputum examination Skin tests Endoscopic examination Lung biopsy Thoracentesis Hematology,
More informationVentilator-associated pneumonia
Respirology (2009) 14 (Suppl. 2) S51 S58 doi: 10.1111/j.1400-1843.2009.01577.x CHAPTER VIII Ventilator-associated pneumonia SUMMARY Ventilator-associated pneumonia is a pneumonia that develops initially
More informationPreventing & Controlling the Spread of Infection
Preventing & Controlling the Spread of Infection Contributors: Alice Pong M.D., Hospital Epidemiologist Chris Abe, R.N., Senior Director Ancillary and Support Services Objectives Review the magnitude of
More informationBacteriological profile and outcome of Ventilator associated pneumonia in Intensive care unit of a tertiary care centre
ORIGINAL ARTICLE ASIAN JOURNAL OF MEDICAL SCIENCES Bacteriological profile and outcome of Ventilator associated pneumonia in Intensive care unit of a tertiary care centre Ravi K 1, Maithili TM 2, David
More informationInvasive Pulmonary Aspergillosis in
Infection & Sepsis Symposium Porto, April 1-3, 2009 Invasive Pulmonary Aspergillosis in Non-Immunocompromised Patients Stijn BLOT, PhD General Internal Medicine & Infectious Diseases Ghent University Hospital,
More informationA Retrospective Study of Rigid Bronchoscopy in 58 Paediatric Cases with Acute Respiratory Distress
International Journal of Scientific and Research Publications, Volume 4, Issue 12, December 2014 1 A Retrospective Study of Rigid Bronchoscopy in 58 Paediatric Cases with Acute Respiratory Distress Dr.
More informationStroke-associated pneumonia: aetiology and diagnostic challenges
Stroke-associated pneumonia: aetiology and diagnostic challenges Craig J Smith Greater Manchester Comprehensive Stroke Centre, Salford Royal NHS Foundation Trust University of Manchester Smith and Tyrrell,
More informationUpper...and Lower Respiratory Tract Infections
Upper...and Lower Respiratory Tract Infections Robin Jump, MD, PhD Cleveland Geriatric Research Education and Clinical Center (GRECC) Louis Stokes Cleveland VA Medical Center Case Western Reserve University
More informationGuidelines. 14 Nov Marc Bonten
Guidelines 14 Nov 2014 Marc Bonten Treatment of Community-Acquired Pneumonia SWAB/ NVALT guideline 2011, replaced SWAB guideline 2005 Empirical treatment must cover the most likely causative pathogen.
More informationUnderstanding the NHSN Ventilator Associated Event (VAE) Definition
Understanding the NHSN Ventilor Associed Event (VAE) Definition Disclosures Honorarium from Sage Shilla Pel OD, CIC Clinical Epidemiologist Scripps Mercy San Diego Objectives Learn how to use the new VAE
More informationFrom the labo to the ICU: Surveillance cultures in daily ICU practice. Pieter Depuydt MD PhD Dept. Intensive Care Ghent University Hospital
From the labo to the ICU: Surveillance cultures in daily ICU practice Pieter Depuydt MD PhD Dept. Intensive Care Ghent University Hospital Question 1: What is the current practice of surveillance cultures
More informationThe Impact of a Unique Airway Clearance System on Airway Mechanics in Ventilated Patients
The Impact of a Unique Airway Clearance System on Airway Mechanics in Ventilated Patients Schofield, L. 1, Shorr, A.F. 2, Washington, J. 1, Carlson, M. 1, Wagner, W. 1.1 McLaren Northern Michigan Hospital,
More informationCritical Care Nursing Theory. Pneumonia. - Pneumonia is an acute infection of the pulmonary parenchyma
- is an acute infection of the pulmonary parenchyma - is a common infection encountered by critical care nurses when it complicates the course of a serious illness or leads to acute respiratory distress.
More informationGuidelines 2017 for the management of hospitalacquired pneumonia (HAP) and. ventilator-associated. pneumonia (VAP)
Guidelines 2017 for the management of hospitalacquired pneumonia (HAP) and ventilator-associated Modifiez le style des sous-titres du masque pneumonia (VAP) Filip Moerman Présentation pour les soins int
More informationINDEPENDENT LUNG VENTILATION
INDEPENDENT LUNG VENTILATION Giuseppe A. Marraro, MD Director Anaesthesia and Intensive Care Department Paediatric Intensive Care Unit Fatebenefratelli and Ophthalmiatric Hospital Milan, Italy gmarraro@picu.it
More informationSteroids in ARDS: if, when, how much? John Fowler, MD, FACEP Dept. of Emergency Medicine Kent Hospital, İzmir, Türkiye
Steroids in ARDS: if, when, how much? John Fowler, MD, FACEP Dept. of Emergency Medicine Kent Hospital, İzmir, Türkiye Steroids in ARDS: conclusion Give low-dose steroids if indicated for another problem
More informationProspective audit and feedback of piperacillin-tazobactam use in a 1115 bed acute care hospital
Prospective audit and feedback of piperacillin-tazobactam use in a 1115 bed acute care hospital Final Results Nathan Beahm, BSP, PharmD(student) September 10, 2016 Objectives Review background information
More informationPulmonary Care for Patients with Mitochondrial Disorders
Pulmonary Care for Patients with Mitochondrial Disorders Rajeev Bhatia, MD, MBBS, DCH, FAAP Pediatric Pulmonologist Assistant Professor of Pediatrics, NEOMED Medical Director, Clinical Exercise Physiology
More informationCOMMISSION ON ACCREDITATION FOR RESPIRATORY CARE TMC DETAILED CONTENT OUTLINE COMPARISON
A. Evaluate Data in the Patient Record I. PATIENT DATA EVALUATION AND RECOMMENDATIONS 1. Patient history e.g., admission data orders medications progress notes DNR status / advance directives social history
More informationAbstract. Introduction
ORIGINAL ARTICLE INFECTIOUS DISEASES Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care
More informationImpact of humidification and gas warming systems on ventilatorassociated
Online Data Supplement Impact of humidification and gas warming systems on ventilatorassociated pneumonia. Jean-Claude Lacherade, M.D. 1, Marc Auburtin, M.D. 2, Charles Cerf, M.D. 3, Andry Van de Louw,
More informationCOPD exacerbation. Dr. med. Frank Rassouli
Definition according to GOLD report: - «An acute event - characterized by a worsening of the patients respiratory symptoms - that is beyond normal day-to-day variations - and leads to a change in medication»
More informationUsefulness of Induced Sputum and Fibreoptic Bronchoscopy Specimens in the Diagnosis of Pulmonary Tuberculosis
The Journal of International Medical Research 2005; 33: 260 265 Usefulness of Induced Sputum and Fibreoptic Bronchoscopy Specimens in the Diagnosis of Pulmonary Tuberculosis L SAGLAM 1, M AKGUN 1 AND E
More informationVAP & CAUTI. CPT. Pasri Maharom MD, MPH Nov 22, 2016
VAP & CAUTI CPT. Pasri Maharom MD, MPH Nov 22, 2016 Pooled Prevalence of HAIs in Southeast Asia Clin Infect Dis 2015;60(11):1690-9. Pooled Incidence Density of VAP in Southeast Asia Clin Infect Dis 2015;60(11):1690-9.
More information